ClinicalTrials HQ

A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight

A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight

Active, not recruiting · NCT06643728 · Registry updated 2026-05-26
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or OverweightBody Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition, platelet-type bleeding disorder 10Active, not recruitingPhase 22026-05-26NCT06643728

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Eli Lilly and Company370

12 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Altus ResearchLake WorthUnited States4
Central Research AssociatesBirminghamUnited States11
Clinical Neuroscience Solutions, Inc. dba CNS HealthcareJacksonvilleUnited States3
Diablo Clinical Research, Inc.Walnut CreekUnited States30
East-West Medical Research InstituteHonoluluUnited States18
Eastside Research AssociatesRedmondUnited States16
Great Lakes Clinical Trials - RavenswoodChicagoUnited States13
Keystone Clinical StudiesPlymouth MeetingUnited States7
Pinnacle Research Group, LLCAnnistonUnited States14
Rainier Clinical Research CenterRentonUnited States19
SKY Integrative Medical Center/SKYCRNGRidgelandUnited States7
Suncoast Research GroupMiamiUnited States5